Journal article
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
Abstract
BACKGROUND: Studies have challenged the appropriateness of accepted blood pressure targets. We hypothesised that different levels of low blood pressure are associated with benefit for some, but harm for other outcomes.
METHODS: In this analysis, we assessed the previously reported outcome data from high-risk patients aged 55 years or older with a history of cardiovascular disease, 70% of whom had hypertension, from the ONTARGET and TRANSCEND …
Authors
Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K
Journal
The Lancet, Vol. 389, No. 10085, pp. 2226–2237
Publisher
Elsevier
Publication Date
6 2017
DOI
10.1016/s0140-6736(17)30754-7
ISSN
0140-6736
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsBenzimidazolesBenzoatesBlood PressureCardiovascular DiseasesDrug Therapy, CombinationFemaleFollow-Up StudiesHospitalizationHumansHypertensionHypotensionMaleMiddle AgedMulticenter Studies as TopicRamiprilRandomized Controlled Trials as TopicTelmisartan